NA Sarcopenia Treatment Market - Industry Trends and Forecast to 2034

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	166 Pages	Data Bridge Market Research	October, 2023	DAABD18360522

Best Price Guarantee
Price	from $3,500
Length	166 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360522

NA Sarcopenia Treatment Market - Industry Trends and Forecast to 2034

The North America sarcopenia treatment market is expected to reach USD 1,814,892.90 thousand by 2030 from USD 1,235,920.05 thousand in 2022, growing at a CAGR of 5.0% in the forecast period of 2023 to 2030.
Market Segmentation
North America Sarcopenia Treatment Market, By Treatment Type (Medications, Vitamin/Dietary Supplements, and Others), Type (Primary Sarcopenia and Secondary Sarcopenia), Stages (Pre-Sarcopenia, Sarcopenia, and Severe Sarcopenia), Route Of Administration (Oral, Injectable, and Others), Gender (Male and Female), End User (Hospitals, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada, Mexico,) - Industry Trends and Forecast to 2030

Overview of North America Sarcopenia Treatment Market Dynamics

Driver
• Rising prevalence of sarcopenia

Restraint

• Lack of standardized diagnosis

Opportunity

• Strategic initiatives by key market players

Market Players

Some of the key market players operating in the North America sarcopenia treatment market are listed below:
• Abbott
• Nestlé Health Science (A subsidiary of Nestlé S.A.)
• Novartis AG
• Sanofi
• Haleon Group of Companies
• BASF SE
• DSM
• Fermenta Biotech Limited
• AstaReal Co., Ltd.
• Metagenics
• BioThrive Sciences
• Wellona Pharma
• The Vitamin Company India
• Healing Pharma India Pvt. Ltd
• Others

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Sarcopenia Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Treatment Type Segment Lifeline Curve; 2.8 Market End User Coverage Grid; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces Model; 4.3 Current Status Of Emerging Drugs For Sarcopenia Treatment
5 North America Sarcopenia Treatment Market: Regulations: 5.1 Regulations In U.S.; 5.2 Regulations In Europe; 5.3 Regulations In Australia; 5.4 Regulations In South Africa
6 Market Overview: 6.1 Drivers; 6.1.1 Rising Prevalence Of Sarcopenia; 6.1.2 Growing Awareness Of Sarcopenia And Its Detrimental Effects On Health; 6.1.3 Lifestyle Factors Such As Poor Nutrition And Sedentary Behaviour; 6.2 Restraints; 6.2.1 Lack Of Standardized Diagnosis; 6.2.2 High Cost Of Treatment And Interventions; 6.3 Opportunities; 6.3.1 Strategic Initiatives By Market Players; 6.3.2 Increasing Research And Development Activities; 6.4 Challenges; 6.4.1 Complications Associated With The Sarcopenia Treatment; 6.4.2 Stringent Government Rules And Regulation For Product Approval
7 North America Sarcopenia Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Vitamin/Dietary Supplements; 7.2.1 Vitamin Supplements; 7.2.2 Protein Supplements; 7.2.3 Fatty Acid Supplements; 7.2.4 Creatine; 7.2.5 Whey Proteins; 7.2.6 L-carnitine; 7.2.7 Soy; 7.2.8 Beta-alanine; 7.2.9 Ostarine; 7.2.10 Collagen Peptides; 7.2.11 Ligandrol; 7.2.12 Branch-chain Amino Acids; 7.2.13 Hydroxymethylbutyrate (Hmb); 7.2.14 Medium Chain Triglycerides; 7.2.15 Others; 7.3 Medications; 7.3.1 Off Label Drugs; 7.3.2 Emerging Drugs; 7.3.2.1 Ace Inhibitors; 7.3.2.2 Appetite Stimulants; 7.3.2.3 Oral Antidiabetic Drugs; 7.3.2.4 Others; 7.4 Others 8 North America Sarcopenia Treatment Market, By Type; 8.1 Overview; 8.2 Primary Sarcopenia; 8.2.1 Vitamin/Dietary Supplements; 8.2.2 Medications; 8.2.3 Others; 8.3 Secondary Sarcopenia; 8.3.1 Vitamin/Dietary Supplements; 8.3.2 Medications; 8.3.3 Others
9 North America Sarcopenia Treatment Market, By Stages: 9.1 Overview; 9.2 Pre-sarcopenia; 9.3 Sarcopenia; 9.4 Severe Sarcopenia
10 North America Sarcopenia Treatment Market, By Route Of Administration: 10.1 Overview; 10.2 Oral; 10.3 Injectables; 10.4 Others
11 North America Sarcopenia Treatment Market, By Gender: 11.1 Overview; 11.2 Male; 11.3 Female
12 North America Sarcopenia Treatment Market, By End User: 12.1 Overview; 12.2 Hospitals; 12.2.1 Public; 12.2.2 Private; 12.3 Specialty Clinics; 12.4 Home Healthcare; 12.5 Others 13 North America Sarcopenia Treatment Market, By Distribution Channel; 13.1 Overview; 13.2 Direct Tender; 13.3 Retail Sales; 13.3.1 Hospital Pharmacies; 13.3.2 Online Pharmacies; 13.3.3 Others; 13.4 Others
14 North America Sarcopenia Treatment Market, By Region: 14.1 North America; 14.1.1 U.S.; 14.1.2 Canada; 14.1.3 Mexico
15 North America Sarcopenia Treatment Market, Company Landscape: 15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile: 17.1 Abbott; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Development; 17.2 Nestlé Health Science (A Subsidiary Of Nestlé S.A.); 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development; 17.3 Novartis Ag; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Pipeline Portfolio; 17.3.6 Recent Development; 17.4 Sanofi; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Development; 17.5 Haleon Group Of Companies.; 17.5.1 Company Snapshot; 17.5.2 Revenue Analysis; 17.5.3 Company Share Analysis; 17.5.4 Product Portfolio; 17.5.5 Recent Development; 17.6 Astareal Co., Ltd.; 17.6.1 Company Snapshot; 17.6.2 Product Portfolio; 17.6.3 Recent Development; 17.7 Basf Se; 17.7.1 Company Snapshot; 17.7.2 Revenue Analysis; 17.7.3 Product Portfolio; 17.7.4 Recent Development; 17.8 Biogen Sa; 17.8.1 Company Snapshot; 17.8.2 Product Portfolio; 17.8.3 Recent Development; 17.9 Biothrive Sciences; 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Dsm; 17.10.1 Company Snapshot; 17.10.2 Revenue Analysis; 17.10.3 Product Portfolio; 17.10.4 Recent Development; 17.11 Fermenta Biotech Limited; 17.11.1 Company Snapshot; 17.11.2 Revenue Analysis; 17.11.3 Product Portfolio; 17.11.4 Recent Development 17.12 Healing Pharma India Pvt. Ltd.; 17.12.1 Company Snapshot; 17.12.2 Product Portfolio; 17.12.3 Recent Development; 17.13 Metagenics; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 The Vitamin Company India; 17.14.1 Company Snapshot; 17.14.2 Product Portfolio; 17.14.3 Recent Development; 17.15 Wellona Pharma; 17.15.1 Company Snapshot; 17.15.2 Product Portfolio; 17.15.3 Recent Development; 17.16 Armgo Pharma, Inc.; 17.16.1 Company Snapshot; 17.16.2 Pipeline Portfolio; 17.16.3 Recent Development; 17.17 Biophytis; 17.17.1 Company Snapshot; 17.17.2 Pipeline Portfolio; 17.17.3 Recent Development; 17.18 Dystrogen Therapeutics Corp; 17.18.1 Company Snapshot; 17.18.2 Pipeline Portfolio; 17.18.3 Recent Development; 17.19 Immunoforge Inc.; 17.19.1 Company Snapshot; 17.19.2 Pipeline Portfolio; 17.19.3 Recent Development; 17.20 Mymd Pharmaceuticals; 17.20.1 Company Snapshot; 17.20.2 Pipeline Portfolio; 17.20.3 Recent Development; 17.21 Nmd Pharma A/S; 17.21.1 Company Snapshot; 17.21.2 Pipeline Portfolio; 17.21.3 Recent Development; 17.22 Oncocross Co., Ltd.; 17.22.1 Company Snapshot; 17.22.2 Pipeline Portfolio; 17.22.3 Recent Development; 17.23 Opko Health, Inc.; 17.23.1 Company Snapshot; 17.23.2 Revenue Analysis; 17.23.3 Pipeline Portfolio; 17.23.4 Recent Development; 17.24 Regeneron Pharmaceuticals Inc.; 17.24.1 Company Snapshot; 17.24.2 Revenue Analysis; 17.24.3 Pipeline Portfolio; 17.24.4 Recent Development; 17.25 Rejuvenate Biomed Nv; 17.25.1 Company Snapshot; 17.25.2 Pipeline Portfolio; 17.25.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 Current Status Of The Development Of Drug For Sarcopenia Treatment; Table 2 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 3 North America Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 4 North America Vitamin/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 5 North America Medications In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 6 North America Medicatinons In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 7 North America Off-lable Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 8 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 9 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 10 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 11 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 12 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 13 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 14 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 15 North America Pre-sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 16 North America Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 17 North America Severe Sarcopenia In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 18 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 19 North America Oral In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 20 North America Injectables In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 21 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 22 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 23 North America Male In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 24 North America Female In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 25 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 26 North America Hospitals In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 27 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 28 North America Specialty Clinics In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 29 North America Home Healthcare In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 30 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 31 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 32 North America Direct Tender In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 33 North America Retail Sales In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 34 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 35 North America Others In Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 36 North America Sarcopenia Treatment Market, By Region, 2021-2030 (Usd Thousand); Table 37 North America Sarcopenia Treatment Market, By Country, 2021-2030 (Usd Thousand); Table 38 North America Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 39 North America Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 40 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 41 North America Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 42 North America Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 43 North America Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 44 North America Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 45 North America Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 46 North America Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 47 North America Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 48 North America Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 49 North America Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 50 North America Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 51 North America Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 52 North America Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 53 U.S. Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 54 U.S. Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 55 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 56 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 57 U.S. Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 58 U.S. Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 59 U.S. Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 60 U.S. Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 61 U.S. Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 62 U.S. Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 63 U.S. Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 64 U.S. Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 65 U.S. Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 66 U.S. Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 67 U.S. Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 68 U.S. Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 69 Canada Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 70 Canada Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 71 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 72 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 73 Canada Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 74 Canada Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 75 Canada Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 76 Canada Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 77 Canada Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 78 Canada Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 79 Canada Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 80 Canada Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 81 Canada Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 82 Canada Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 83 Canada Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 84 Canada Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 85 Mexico Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 86 Mexico Medications In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 87 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 88 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Volume); Table 89 Mexico Off-label Drugs In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Asp); Table 90 Mexico Vitamins/Dietary Supplements In Sarcopenia Treatment Market, By Treatment Type, 2021-2030 (Usd Thousand); Table 91 Mexico Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 92 Mexico Primary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 93 Mexico Secondary Sarcopenia In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 94 Mexico Sarcopenia Treatment Market, By Stages, 2021-2030 (Usd Thousand); Table 95 Mexico Sarcopenia Treatment Market, By Route Of Administration, 2021-2030 (Usd Thousand); Table 96 Mexico Sarcopenia Treatment Market, By Gender, 2021-2030 (Usd Thousand); Table 97 Mexico Sarcopenia Treatment Market, By End User, 2021-2030 (Usd Thousand); Table 98 Mexico Hospitals In Sarcopenia Treatment Market, By Type, 2021-2030 (Usd Thousand); Table 99 Mexico Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand); Table 100 Mexico Retail Sales In Sarcopenia Treatment Market, By Distribution Channel, 2021-2030 (Usd Thousand)
List Of Figures: Figure 1 North America Sarcopenia Treatment Market: Segmentation; Figure 2 North America Sarcopenia Treatment Market: Data Triangulation; Figure 3 North America Sarcopenia Treatment Market: Droc Analysis; Figure 4 North America Sarcopenia Treatment Market: North America Vs Regional Market Analysis; Figure 5 North America Sarcopenia Treatment Market: Company Research Analysis; Figure 6 North America Sarcopenia Treatment Market: Interview Demographics; Figure 7 North America Sarcopenia Treatment Market: Market End Users Coverage Grid; Figure 8 North America Sarcopenia Treatment Market: Dbmr Market Position Grid; Figure 9 North America Sarcopenia Treatment Market: Vendor Share Analysis; Figure 10 North America Sarcopenia Treatment Market: Segmentation; Figure 11 The Rising Prevalence Of Sarcopenia And Growing Awareness Of Sarcoepnia And Its Detrimental Effect On Health Are Expected To Drive The Growth Of The North America Sarcopenia Treatment Market From 2023 To 2030; Figure 12 Vitamin/Dietary Supplements Segment Is Expected To Account For The Largest Share Of The North America Preclinical Market In 2023 And 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Sarcopenia Treatment Market; Figure 14 North America Sarcopenia Treatment Market: By Treatment Type, 2022; Figure 15 North America Sarcopenia Treatment Market: By Treatment Type, 2023-2030 (Usd Thousand); Figure 16 North America Sarcopenia Treatment Market: By Treatment Type, Cagr (2023-2030); Figure 17 North America Sarcopenia Treatment Market: By Treatment, Lifeline Curve; Figure 18 North America Sarcopenia Treatment Market: By Type, 2022; Figure 19 North America Sarcopenia Treatment Market: By Type, 2023-2030 (Usd Thousand); Figure 20 North America Sarcopenia Treatment Market: By Type, Cagr (2023-2030); Figure 21 North America Sarcopenia Treatment Market: By Type, Lifeline Curve; Figure 22 North America Sarcopenia Treatment Market: By Stages, 2022; Figure 23 North America Sarcopenia Treatment Market: By Stages, 2023-2030 (Usd Thousand); Figure 24 North America Sarcopenia Treatment Market: By Stages, Cagr (2023-2030); Figure 25 North America Sarcopenia Treatment Market: By Stages, Lifeline Curve; Figure 26 North America Sarcopenia Treatment Market: By Route Of Administration, 2022; Figure 27 North America Sarcopenia Treatment Market: By Route Of Administration (2023-2030); Figure 28 North America Sarcopenia Treatment Market: By Route Of Administration (2023-2030); Figure 29 North America Sarcopenia Treatment Market: Lifeline Curve; Figure 30 North America Sarcopenia Treatment Market: By Gender, 2022; Figure 31 North America Sarcopenia Treatment Market: By Gender, 2023-2030 (Usd Thousand); Figure 32 North America Sarcopenia Treatment Market: By Gender, Cagr (2023-2030); Figure 33 North America Sarcopenia Treatment Market: By Gender, Lifeline Curve; Figure 34 North America Sarcopenia Treatment Market: By End User, 2022; Figure 35 North America Sarcopenia Treatment Market: By End User, 2023-2030 (Usd Thousand); Figure 36 North America Sarcopenia Treatment Market: By End User, Cagr (2023-2030); Figure 37 North America Sarcopenia Treatment Market: By End User, Lifeline Curve; Figure 38 North America Sarcopenia Treatment Market: By Distribution Channel, 2022; Figure 39 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 40 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 41 North America Sarcopenia Treatment Market: By Distribution Channel, 2023-2030 (Usd Thousand); Figure 42 North America Sarcopenia Treatment Market: Snapshot (2022); Figure 43 North America Sarcopenia Treatment Marketstructural Health Monitoring Market: Company Share 2022 (%)